Financial Instruments, Balance Sheet Location (Details)	9 Months Ended
	Mar. 27, 2021
Derivatives, Fair Value [Line Items]
Derivatives, Use of Derivatives	Derivative instruments and hedging activitiesThe Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and European Euro, Indian Rupee, Taiwan New Dollar, South Korean Won, Chinese Yuan, Japanese Yen, Singapore Dollar, and Canadian Dollar expenditures for sales offices and research and development activities undertaken outside of the U.S.The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 27, 2021 and June 27, 2020, the notional amounts of the forward contracts the Company held to purchase international currencies were $75.0 million and $61.6 million, respectively and the notional amounts of forward contracts the Company held to sell international currencies in exchange for U.S. Dollars were $1.6 million and $0, respectively.Derivatives not designated as hedging instrumentsAs of March 27, 2021 and June 27, 2020, the notional amounts of the forward contracts the Company held to purchase international currencies were $41.0 million and $32.3 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $14.1 million and $12.0 million, respectively.